NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0 (+0%)
At Close: May 21, 2024
Organogenesis Holdings reports preliminary Q4 revenue results
12:36pm, Monday, 13'th Jan 2020
Organogenesis Holdings (NASDAQ:
ORGO
) says it
expects
Q4 Net revenue to be between $72.6M to $74.6M (+14% to +17% Y/Y) vs. consensus of $70.39M, comprising of Advanced Wound Care products revenue gr
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2019
12:00pm, Monday, 13'th Jan 2020
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2019
12:00pm, Monday, 13'th Jan 2020
CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...
IFR US ECM Weekly Wrap-up
11:05pm, Friday, 22'nd Nov 2019
NEW YORK, Nov 22 (IFR) - WEEKLY TOTAL $9.6bn – IPO $993m – ABB/BLOCK $6.3bn – FOLLOW-ON $1.65bn – CB $705m Monday
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
03:04am, Friday, 22'nd Nov 2019
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
12:25pm, Wednesday, 20'th Nov 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Allergan
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
09:01pm, Tuesday, 19'th Nov 2019
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
Organogenesis Holdings Inc. Reports Third Quarter and Nine Months of 2019 Financial Results
09:05pm, Tuesday, 12'th Nov 2019
CANTON, Mass., Nov. 12, 2019 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and.
Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?
04:22pm, Monday, 11'th Nov 2019
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Latest Advanced Wound Care Research from Organogenesis Highlighted at SAWC Fall 2019
08:05pm, Friday, 11'th Oct 2019
CANTON, Mass. and LAS VEGAS, Oct. 11, 2019 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and.
